Journal Home
Search for

Volume 30, Issue 3, Pages 253-259 (April 2006)


View previous. 16 of 18 View next.

An intervention program for ADHD in patients with substance use disorders: Preliminary results of a field trial

M. Anne Goossensen, Ph.D.aCorresponding Author Informationemail address, Geurt van de Glind, M.A.b, Pieter-Jan Carpentier, M.D.c, Riek M.A. Wijsen, M.A.d, Daniëlle van Duin, M.Sc.b, J.J. Sandra Kooij, M.D.e

Received 18 July 2005; received in revised form 12 December 2005; accepted 20 December 2005.

Abstract 

The comorbidity of attention deficit hyperactivity disorder (ADHD) is frequently not well recognized in substance abuse treatment institutions in The Netherlands. As a consequence, patients with substance use disorder (SUD) and ADHD often receive suboptimal treatment. To prevent every treatment center from having to invent its own diagnostic procedure and intervention for ADHD, a national working group was established. This group developed an intervention program for the screening, diagnosis, and treatment of ADHD in patients with SUD. This article describes the development and content of this intervention program. An important part of this development was testing the intervention program in two addiction treatment centers in The Netherlands. Systematic screening of ADHD was part of the test. A self-report questionnaire was used. Subjects with positive screening results were referred for the diagnostic procedure. Nine hundred twenty-eight screenings were performed: 207 screened positive, 115 came for further diagnostics, and 65 were ultimately diagnosed with ADHD.

a Institute of Health Policy and Management, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands

b Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands

c Reinier van Arkel Groep, 's-Hertogenbosch and Novadic-Kentron, Network for Addiction Treatment Services, Sint-Oedenrode, The Netherlands

d De Grift, Regional Addiction Treatment Centre Gelderland, The Netherlands

e PsyQ, Department of Adult ADHD, The Hague, The Netherlands

Corresponding Author InformationCorresponding author. Tel.: +31 010 408 8712.

 This project was supported by ZonMw, The Netherlands Organization for Health Research and Development (grant 310-00-029).

PII: S0740-5472(06)00008-0

doi:10.1016/j.jsat.2005.12.004


View previous. 16 of 18 View next.